Published in J Clin Invest on January 15, 1998
Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy. Proc Natl Acad Sci U S A (2001) 1.48
Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol (2008) 1.04
Mechanism of cellular rejection in transplantation. Pediatr Nephrol (2010) 1.01
Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model (2007) 0.98
Immune recognition and rejection of allogeneic skin grafts. Immunotherapy (2011) 0.97
Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients. J Immunol (2011) 0.96
Immunosuppression for lung transplantation. Front Biosci (Landmark Ed) (2009) 0.95
A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol (2012) 0.94
Antibodies reactive to non-HLA antigens in transplant glomerulopathy. J Am Soc Nephrol (2011) 0.91
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg (2005) 0.91
Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts. Transpl Immunol (2009) 0.91
Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol (2010) 0.91
Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol (2012) 0.91
Administration of the stress protein gp96 prolongs rat cardiac allograft survival, modifies rejection-associated inflammatory events, and induces a state of peripheral T-cell hyporesponsiveness. Cell Stress Chaperones (2007) 0.90
Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease. Am J Respir Cell Mol Biol (2005) 0.89
Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci (2008) 0.89
Lung transplantation: infection, inflammation, and the microbiome. Semin Immunopathol (2011) 0.86
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin Exp Immunol (2005) 0.85
FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol (2007) 0.84
Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation. Transplantation (2009) 0.84
Predicting alloreactivity in transplantation. J Immunol Res (2014) 0.84
Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates. J Immunol (2011) 0.83
Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research. Transplantation (2016) 0.81
Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis. Clin Diagn Lab Immunol (2004) 0.81
Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP. Hum Immunol (2014) 0.80
Loss of tolerance to self after transplant. Semin Immunopathol (2011) 0.79
Activation-induced T cell death, and aberrant T cell activation via TNFR1 and CD95-CD95 ligand pathway in stable cardiac transplant recipients. Clin Exp Immunol (2002) 0.79
Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant (2015) 0.79
Diversity of the CD4 T Cell Alloresponse: The Short and the Long of It. Cell Rep (2016) 0.78
In vitro assays of allosensitization. Pediatr Transplant (2008) 0.77
Class I MHC allochimeric presentation of composite immunogenic and self epitopes induces tolerance to genetically diverse rat strains. Cell Immunol (2007) 0.77
Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets. Cureus (2015) 0.76
Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant (2017) 0.75
Monitoring T cell alloreactivity after organ transplantation. Clin Exp Immunol (2005) 0.75
A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse. Front Immunol (2017) 0.75
Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-γ production by Th1 cells. Kidney Int (2016) 0.75
HLA Genotyping in Patients with End-Stage Renal Disease Waiting For Cadaveric Renal Transplantation in Federation of Bosnia and Herzegovina. Open Access Maced J Med Sci (2017) 0.75
Are we ready for the use of foxp3(+) regulatory T cells for immunodiagnosis and immunotherapy in kidney transplantation? J Transplant (2012) 0.75
Monitoring alloimmune response in kidney transplantation. J Nephrol (2016) 0.75
Increasing transplant mass results in long-term allograft survival and recovery from transplant vasculopathy. J Clin Immunol (2003) 0.75
Antigen-specific interaction between T and B cells. Nature (1985) 10.64
Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol (1993) 4.23
Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today (1993) 3.62
Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol (1987) 2.85
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med (1995) 2.62
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med (1994) 2.45
Do B cells drive the diversification of immune responses? Immunol Today (1993) 2.31
Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis (1990) 1.84
Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med (1989) 1.65
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching. Lancet (1995) 1.55
Epitope spreading. Curr Opin Immunol (1996) 1.34
The role of anti-HLA antibodies in heart transplantation. Transplantation (1991) 1.27
Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures. J Immunol (1988) 1.26
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today (1995) 1.16
Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc (1989) 1.12
Role of indirect allorecognition in allograft rejection. Int Rev Immunol (1996) 1.10
Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J Immunol (1992) 1.09
Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J Immunol (1994) 1.05
The distinctive specificity of antigen-specific suppressor T cells. Immunol Today (1991) 0.99
Humoral immune responses after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery (1989) 0.94
Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant (1992) 0.93
MHC class II binding of peptides derived from HLA-DR 1. J Immunol (1992) 0.92
The contribution of peptides to T cell allorecognition and allograft rejection. Int Rev Immunol (1996) 0.90
Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation (1996) 0.89
Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation (1994) 0.87
Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant (1992) 0.87
New approaches to specific immunomodulation in transplantation. Int Rev Immunol (1996) 0.86
Detection of donor-specific hyporesponsiveness following late failure of human renal allografts. Kidney Int (1996) 0.86
Towards understanding the pathophysiology of chronic rejection. Clin Investig (1992) 0.86
Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett (1992) 0.85
Indirect T cell recognition in allograft rejection. Int Rev Immunol (1996) 0.84
The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation (1995) 0.84
Evidence for clonal anergy as a mechanism responsible for the maintenance of transplantation tolerance. Eur J Immunol (1993) 0.82
Correlation of histocompatibility matching with graft rejection and survival after cardiac transplantation in man. Lancet (1971) 0.82
Regulation of human aortic endothelial cell-derived mesenchymal growth factors by allogeneic lymphocytes in vitro. A potential mechanism for cardiac allograft vasculopathy. J Clin Invest (1993) 0.82
HLA compatibility and cardiac transplant recipient survival. Ann Thorac Surg (1987) 0.81
Endothelial adhesion molecules in heart transplantation. J Heart Lung Transplant (1992) 0.80
Pathophysiology of allograft arteriosclerosis. Transplant Proc (1993) 0.80
Indirect recognition of donor MHC Class II antigens in human transplantation. Clin Immunol Immunopathol (1996) 0.80
New strategies for early diagnosis of heart allograft rejection. Transplantation (1997) 0.79
Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response. Transplantation (1996) 0.79
Pathophysiology of chronic rejection. Transplant Proc (1996) 0.79
Eicosanoids and platelet activating factor mechanisms in organ rejection. Transplant Proc (1988) 0.77
Growth factors and cell proliferation in human transplant arteriosclerosis. J Heart Lung Transplant (1992) 0.77
Anti-HLA antibodies and heart allograft survival. Transplant Proc (1989) 0.77
Analysis of proteolytic processing during specific antigen presentation. Cell Immunol (1987) 0.77
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol Cell (2000) 10.92
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell (1990) 8.30
Correlation between transcriptome and interactome mapping data from Saccharomyces cerevisiae. Nat Genet (2001) 7.16
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA (1999) 5.25
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 3.91
Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol (2002) 3.91
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci (2001) 3.72
Tas1r3, encoding a new candidate taste receptor, is allelic to the sweet responsiveness locus Sac. Nat Genet (2001) 3.65
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess (2007) 3.43
Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet (1996) 3.30
Purification and biological activity of thymosin, a hormone of the thymus gland. Proc Natl Acad Sci U S A (1972) 3.24
Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol (2008) 3.13
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity (2000) 2.93
Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol (1999) 2.91
RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun (2002) 2.88
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg (2001) 2.80
The SAND domain structure defines a novel DNA-binding fold in transcriptional regulation. Nat Struct Biol (2001) 2.69
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A (1994) 2.61
Requirement of the DEAD-Box protein ded1p for messenger RNA translation. Science (1997) 2.58
Ordered nanoporous arrays of carbon supporting high dispersions of platinum nanoparticles. Nature (2001) 2.58
Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev (1994) 2.42
HIV-1 infection in commercial plasma donors in China. Lancet (1995) 2.42
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia (2006) 2.40
The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32
Rearrangement and transcription of the beta-chain genes of the T-cell antigen receptor in different types of murine lymphocytes. Nature (1985) 2.29
Th1- and Th2-cell commitment during infectious disease: asymmetry in divergent pathways. Trends Immunol (2001) 2.26
Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol (1997) 2.23
The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia (2009) 2.11
Implantable left ventricular assist devices. N Engl J Med (1998) 2.07
Th17 response and its regulation in inflammatory upper airway diseases. Clin Exp Allergy (2015) 2.06
Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol (2006) 2.05
Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg (1997) 2.01
Noninvasive Raman spectroscopy in living mice for evaluation of tumor targeting with carbon nanotubes. Nano Lett (2008) 2.01
31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol (1994) 2.00
A dynamic micro-CT scanner based on a carbon nanotube field emission x-ray source. Phys Med Biol (2009) 1.97
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Rearrangements of T-cell receptor gene YT35 in human DNA from thymic leukaemia T-cell lines and functional T-cell clones. Nature (1984) 1.96
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem (1995) 1.92
Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. Ann Thorac Surg (1992) 1.88
Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. J Clin Microbiol (2001) 1.86
L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation (1997) 1.83
Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst (1992) 1.82
Genetic evaluation for herd life in Canada. J Dairy Sci (1998) 1.82
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation. Health Technol Assess (2010) 1.80
Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. Development (2000) 1.79
Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med (2000) 1.76
Patterns and mechanisms of early Pliocene warmth. Nature (2013) 1.73
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood (1995) 1.73
Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am J Respir Cell Mol Biol (1999) 1.69
Formation of the epicardium studied with the scanning electron microscope. Dev Biol (1978) 1.68
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior. Oncogene (2010) 1.64
Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. Hepatology (1999) 1.64
Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent. Thromb Haemost (1996) 1.63
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Rearrangement and expression of the alpha, beta, and gamma chain T cell receptor genes in human thymic leukemia cells and functional T cells. J Exp Med (1986) 1.62
Influence of thymosin on cell-mediated and humoral immune responses in normal and in immunologically deficient mice. J Immunol (1970) 1.62
Induction of xenoreactive CD4+ T-cell anergy by suppressor CD8+CD28- T cells. Transplantation (2000) 1.60
Removing a barrier to computer-based outbreak and disease surveillance--the RODS Open Source Project. MMWR Morb Mortal Wkly Rep (2004) 1.60
Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg (1998) 1.58
Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC. J Mol Cell Cardiol (2006) 1.58
Objective Assessment of Multiresolution Image Fusion Algorithms for Context Enhancement in Night Vision: A Comparative Study. IEEE Trans Pattern Anal Mach Intell (2011) 1.57
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg (1995) 1.56
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene (2012) 1.54
Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis (1995) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
LEUNIG, a putative transcriptional corepressor that regulates AGAMOUS expression during flower development. Proc Natl Acad Sci U S A (2000) 1.52
Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry. Am J Transplant (2012) 1.52
Memory from the dynamics of intrinsic membrane currents. Proc Natl Acad Sci U S A (1996) 1.51
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus (2012) 1.50
Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A (1996) 1.50
Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation (1995) 1.49
The effects of self-hypnosis on quality of life following coronary artery bypass surgery: preliminary results of a prospective, randomized trial. J Altern Complement Med (1995) 1.49
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1994) 1.47
Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol (1986) 1.47
Treatment with low-dose aspirin increased the level LIF and integrin β3 expression in mice during the implantation window. Placenta (2010) 1.46
Syntaxin 4 in 3T3-L1 adipocytes: regulation by insulin and participation in insulin-dependent glucose transport. Mol Biol Cell (1996) 1.45
VAMP2, but not VAMP3/cellubrevin, mediates insulin-dependent incorporation of GLUT4 into the plasma membrane of L6 myoblasts. Mol Biol Cell (2000) 1.45
Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. Int Immunol (1998) 1.44
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
Exposure of the intramyocardial left anterior descending artery. Ann Thorac Surg (1994) 1.43
Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun (1996) 1.43
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation. Health Technol Assess (2011) 1.43
Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. Br J Cancer (2009) 1.43